Diagnosis and management of Bartter syndrome: executive summary of the consensus and recommendations from the European Rare Kidney Disease Reference Network Working Group for Tubular Disorders.

Bartter syndrome hypokalemic metabolic alkalosis inherited hypokalemia salt-losing tubulopathy

Journal

Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470

Informations de publication

Date de publication:
02 2021
Historique:
received: 03 07 2020
revised: 30 09 2020
accepted: 29 10 2020
entrez: 29 1 2021
pubmed: 30 1 2021
medline: 22 6 2021
Statut: ppublish

Résumé

Bartter syndrome is a rare inherited salt-losing renal tubular disorder characterized by secondary hyperaldosteronism with hypokalemic and hypochloremic metabolic alkalosis and low to normal blood pressure. The primary pathogenic mechanism is defective salt reabsorption predominantly in the thick ascending limb of the loop of Henle. There is significant variability in the clinical expression of the disease, which is genetically heterogenous with 5 different genes described to date. Despite considerable phenotypic overlap, correlations of specific clinical characteristics with the underlying molecular defects have been demonstrated, generating gene-specific phenotypes. As with many other rare disease conditions, there is a paucity of clinical studies that could guide diagnosis and therapeutic interventions. In this expert consensus document, the authors have summarized the currently available knowledge and propose clinical indicators to assess and improve quality of care.

Identifiants

pubmed: 33509356
pii: S0085-2538(20)31404-6
doi: 10.1016/j.kint.2020.10.035
pii:
doi:

Types de publication

Practice Guideline Research Support, Non-U.S. Gov't Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

324-335

Informations de copyright

Copyright © 2020 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Auteurs

Martin Konrad (M)

Department of General Pediatrics, University Hospital Münster, Münster, Germany. Electronic address: konradma@uni-muenster.de.

Tom Nijenhuis (T)

Department of Nephrology, Radboud University Medical Center, Nijmegen, The Netherlands.

Gema Ariceta (G)

Pediatric Nephrology, Hospital Universitari Vall d'Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain.

Aurelia Bertholet-Thomas (A)

Université Claude Bernard Lyon 1, Lyon, France.

Lorenzo A Calo (LA)

Department of Medicine (DIMED), Nephrology, Dialysis, Transplantation, University of Padova, Padua, Italy.

Giovambattista Capasso (G)

Division of Nephrology, Department of Translational Medical Sciences, School of Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.

Francesco Emma (F)

Division of Nephrology, Department of Pediatric Subspecialties, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.

Karl P Schlingmann (KP)

Department of General Pediatrics, University Hospital Münster, Münster, Germany.

Mandeep Singh (M)

Fetal Medicine Centre, Southend University Hospital NHS Foundation Trust, Essex, UK.

Francesco Trepiccione (F)

Division of Nephrology, Department of Translational Medical Sciences, School of Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.

Stephen B Walsh (SB)

Department of Renal Medicine, University College London, London, United Kingdom.

Rosa Vargas-Poussou (R)

Hôpital Européen Georges Pompidou, Assistance Publique Hôpitaux de Paris, Centre d'Investigation Clinique, Paris, France; Centre de Référence des Maladies Rénales Héréditaires de l'Enfant et de l'Adulte, Paris, France.

Detlef Bockenhauer (D)

Department of Renal Medicine, University College London, London, United Kingdom; Department of Pediatric Nephrology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH